StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
156
Publishing Date
2022 - 11 - 03
150
2022 - 11 - 02
6
Sector
Commercial services
20
Communications
26
Construction
1
Consumer durables
17
Consumer non-durables
8
Consumer services
17
Distribution services
1
Electronic technology
37
Energy minerals
13
Finance
43
Finance and insurance
7
Health care and social assistance
2
Health services
13
Health technology
156
Industrial services
10
Information
9
Manufacturing
36
Mining, quarrying, and oil and gas extraction
5
Miscellaneous
4
N/a
21
Non-energy minerals
19
Process industries
18
Producer manufacturing
29
Professional, scientific, and technical services
10
Real estate and rental and leasing
1
Retail trade
10
Technology services
55
Transportation
13
Transportation and warehousing
1
Utilities
18
Tags
Afm13
2
Alert
3
America
2
Aml
3
Bio-nc
2
Biocapital
2
Bioforest
2
Biopharma
3
Biotech-bay
5
Biotech-beach
11
Biotechnology
3
Clearance
2
Clinical-trials-phase-ii
4
Clinical-trials-phase-iii
2
Conference
11
Corporation
5
Cystic fibrosis
2
Device
2
Disease
3
Drug
3
Earnings
16
Europe
3
Events
4
Expansion
2
Fibrosis
2
Financial
56
Genetown
5
Glaucoma
2
Global
2
Health
2
Kidney
2
Life
3
Market
4
Meeting
37
Money
2
N/a
85
Nasdaq
3
Omni
2
Ongoing
2
Pharma
5
Pharmaceuticals
15
Phase 1
11
Positive
7
Potential
2
Preclinical
5
Presentation
11
Program
3
Publication
2
Report
11
Research
5
Results
59
Sciences
7
Study
6
System
3
Therapeutics
30
Therapy
3
Treatment
5
Trial
12
Update
15
Week
3
Entities
4d molecular therapeutics inc
1
Abbott laboratories
3
Abbvie inc.
1
Abeona therapeutics inc.
2
Acadia pharmaceuticals inc.
1
Actinium pharmaceuticals, inc.
1
Acutus medical, inc.
1
Adc therapeutics sa
2
Addex therapeutics ltd
3
Aeterna zentaris inc.
1
Affimed n.v.
2
Agios pharmaceuticals, inc.
2
Akouos, inc.
1
Albireo pharma, inc.
1
Aldeyra therapeutics, inc.
1
Allogene therapeutics, inc.
2
Allovir, inc.
1
Alnylam pharmaceuticals, inc.
1
Alpine immune sciences, inc.
1
Amgen inc.
1
Annexon, inc.
1
Apellis pharmaceuticals, inc.
1
Applied genetic technologies corporation
1
Aptose biosciences, inc.
1
Astrazeneca plc
2
Atea pharmaceuticals, inc.
1
Athenex, inc.
1
Atyr pharma, inc.
1
Aurinia pharmaceuticals inc
1
Autolus therapeutics plc
1
Avid bioservices, inc.
1
Beam therapeutics inc.
1
Bicycle therapeutics plc
1
Biolinerx ltd.
1
Biomarin pharmaceutical inc.
1
Brainsway ltd.
1
Bridgebio pharma, inc.
1
Bristol-myers squibb company
2
Bruker corporation
1
C4 therapeutics, inc.
1
Cassava sciences, inc.
1
Eli lilly and company
4
Fate therapeutics, inc.
2
Genmab a/s
4
Geron corporation
2
Glaukos corporation
2
Hercules capital, inc.
2
Intellia therapeutics, inc.
2
Kura oncology, inc.
3
Medtronic plc
3
Neurocrine biosciences, inc.
2
Novartis ag
2
Prothena corporation plc
2
Regeneron pharmaceuticals, inc.
2
Regenxbio inc.
2
Rocket pharmaceuticals, inc.
2
Sanofi
5
Sight sciences inc
2
Sutro biopharma, inc.
3
Teva pharmaceutical industries ltd
2
Symbols
ABBV
1
ABEO
2
ABT
3
ACAD
1
ADCT
2
ADXN
3
AEZS
1
AFIB
1
AFMD
2
AGIO
2
AGTC
1
AKUS
1
ALBO
1
ALDX
1
ALLO
2
ALNY
1
ALPN
1
ALVR
1
AMGN
1
ANNX
1
APLS
1
APTO
1
ATNM
1
ATNX
1
AUPH
1
AUTL
1
AVIR
1
AZN
2
AZNCF
2
BBIO
1
BCYC
1
BEAM
1
BLRX
1
BMRN
1
BMY
2
BRKR
1
BRSYF
1
BWAY
1
FATE
2
GERN
2
GKOS
2
GMAB
4
GNMSF
4
HTGC
2
KURA
3
LLY
4
MDT
3
NBIX
2
NTLA
2
NVS
2
NVSEF
2
PRTA
2
RCKT
2
REGN
2
RGNX
2
SGHT
2
SNY
5
SNYNF
5
STRO
3
TEVJF
2
Exchanges
Amex
3
Nasdaq
144
Nyse
27
Crawled Date
2024 - 03 - 05
135
2024 - 02 - 28
136
2024 - 01 - 08
172
2023 - 11 - 09
171
2023 - 11 - 08
148
2023 - 11 - 07
189
2023 - 11 - 06
207
2023 - 11 - 03
156
2023 - 11 - 02
254
2023 - 11 - 01
248
2023 - 10 - 31
141
2023 - 09 - 07
143
2023 - 09 - 06
137
2023 - 09 - 05
152
2023 - 08 - 10
159
2023 - 08 - 03
166
2023 - 05 - 15
145
2023 - 05 - 11
169
2023 - 05 - 09
161
2023 - 05 - 08
141
2023 - 05 - 04
249
2023 - 05 - 03
230
2023 - 05 - 02
214
2023 - 05 - 01
282
2023 - 03 - 02
141
2023 - 02 - 28
165
2023 - 02 - 23
144
2022 - 11 - 14
144
2022 - 11 - 03
156
2022 - 03 - 01
178
2021 - 11 - 15
149
2021 - 11 - 12
146
2021 - 11 - 10
148
2021 - 11 - 09
153
2021 - 11 - 04
171
2021 - 11 - 02
138
2021 - 11 - 01
137
2021 - 10 - 21
138
2021 - 09 - 09
140
2021 - 09 - 08
149
2021 - 09 - 07
148
2021 - 08 - 09
142
2021 - 08 - 05
164
2021 - 07 - 29
145
2021 - 06 - 01
146
2021 - 05 - 13
135
2021 - 05 - 11
136
2021 - 05 - 10
159
2021 - 05 - 06
163
2021 - 05 - 03
142
2021 - 04 - 27
134
2021 - 03 - 11
138
2021 - 03 - 04
147
2021 - 03 - 02
143
2021 - 02 - 25
156
2021 - 01 - 05
142
2021 - 01 - 04
136
2020 - 12 - 03
146
2020 - 12 - 02
182
2020 - 12 - 01
227
Crawled Time
00:00
6
04:00
1
08:00
2
09:00
3
10:00
2
11:00
14
12:00
17
12:20
16
13:00
43
13:20
10
14:00
16
14:20
1
15:00
5
15:20
1
16:00
1
17:00
2
19:00
7
21:00
2
22:00
1
23:00
6
Source
investors.biomarin.com
1
ir.ateapharma.com
1
ir.auriniapharma.com
1
ir.biolinerx.com
1
www.biospace.com
71
www.catalent.com
1
www.globenewswire.com
65
www.prnewswire.com
14
www.sutrobio.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health technology
crawled date :
2022 - 11 - 03
save search
Prothena Reports Third Quarter 2022 Financial Results and Business Highlights
Published:
2022-11-03
(Crawled : 23:00)
- biospace.com/
PRTA
4
|
$20.56
0.15%
340K
|
Health Technology
|
-65.64%
|
O:
-1.99%
H:
0.55%
C:
-1.64%
financial
results
Verastem Oncology Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
Published:
2022-11-03
(Crawled : 23:00)
- biospace.com/
VSTM
|
$9.31
-3.12%
-3.44%
79K
|
Health Technology
|
98.37%
|
O:
-0.28%
H:
7.69%
C:
2.23%
GERN
|
$3.58
2.29%
1.96%
5.7M
|
Health Technology
|
66.51%
|
O:
0.93%
H:
4.15%
C:
-6.45%
financial
results
ras pathway
Puma Biotechnology Reports Third Quarter 2022 Financial Results
Published:
2022-11-03
(Crawled : 23:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
0.76%
|
O:
-0.91%
H:
0.92%
C:
0.77%
PBYI
|
$4.83
-5.85%
-5.99%
370K
|
Health Technology
|
123.61%
|
O:
0.0%
H:
1.85%
C:
-0.93%
financial
results
RENOVACOR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Renovacor, Inc. - RCOR
Published:
2022-11-03
(Crawled : 23:00)
- prnewswire.com
RCOR
|
$3.2
0.0%
|
|
5.96%
|
O:
-16.89%
H:
11.56%
C:
8.37%
RCKT
4
|
$23.63
-0.17%
-0.13%
920K
|
Health Technology
|
32.9%
|
O:
-1.52%
H:
1.7%
C:
-2.86%
alert
AKOUOS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akouos, Inc. - AKUS
Published:
2022-11-03
(Crawled : 23:00)
- prnewswire.com
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
107.98%
|
O:
0.97%
H:
0.18%
C:
-2.13%
AKUS
|
$13.29
1.07%
3.46%
|
Health Technology
|
0.15%
|
O:
0.0%
H:
0.23%
C:
0.23%
alert
APPLIED GENETIC TECHNOLOGIES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied Genetic Technologies Corporation - AGTC
Published:
2022-11-03
(Crawled : 23:00)
- prnewswire.com
AGTC
|
News
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-4.09%
|
O:
1.24%
H:
1.81%
C:
1.23%
alert
genetic
corporation
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
Published:
2022-11-03
(Crawled : 22:00)
- globenewswire.com
CDTX
|
News
|
$12.29
19.9%
14.15%
64K
|
Health Technology
|
1845.9%
|
O:
1.03%
H:
2.68%
C:
-3.25%
therapeutics
financial
update
results
METTLER-TOLEDO INTERNATIONAL INC. REPORTS THIRD QUARTER 2022 RESULTS
Published:
2022-11-03
(Crawled : 21:00)
- prnewswire.com
MTD
|
$1235.37
-0.48%
0.0%
160K
|
Health Technology
|
0.77%
|
O:
-1.0%
H:
6.92%
C:
5.84%
results
international
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2022
Published:
2022-11-03
(Crawled : 21:00)
- globenewswire.com
IOVA
4
|
$11.71
-1.27%
-1.45%
2.9M
|
Health Technology
|
37.28%
|
O:
5.74%
H:
2.66%
C:
-1.33%
CLLS
|
News
|
$2.5
-4.57%
-3.55%
39K
|
Health Technology
|
2.46%
|
O:
0.82%
H:
0.0%
C:
-4.88%
ALLO
|
$3.04
-9.79%
-10.86%
2.1M
|
Health Technology
|
-68.07%
|
O:
1.68%
H:
0.0%
C:
-3.51%
financial
update
Grifols receives FDA clearance for AlphaID™ At Home, the first free service for U.S. consumers to determine their risk for alpha-1
Published:
2022-11-03
(Crawled : 19:00)
- biospace.com/
GRFS
|
$6.39
-1.39%
-1.25%
960K
|
Health Technology
|
-1.54%
|
O:
-0.46%
H:
0.0%
C:
-1.24%
fda
clearance
risk
free
service
Poseida Therapeutics Announces Oral Presentation Highlighting P-FVIII-101 Gene Therapy at the 64th ASH Annual Meeting & Exposition
Published:
2022-11-03
(Crawled : 19:00)
- biospace.com/
PSTX
|
$2.07
-4.17%
-4.6%
460K
|
Health Technology
|
-45.81%
|
O:
-0.52%
H:
7.63%
C:
6.84%
fviii-101
meeting
therapeutics
presentation
therapy
Neurocrine Biosciences Presents Data on In Vitro Dissolution Performance of INGREZZA® (valbenazine) Capsules at the American Society of Consultant Pharmacists (ASCP) 2022 Annual Meeting
Published:
2022-11-03
(Crawled : 19:00)
- biospace.com/
NBIX
|
News
4
|
$138.97
-0.8%
-0.85%
930K
|
Health Technology
|
13.85%
|
O:
-0.09%
H:
2.71%
C:
1.77%
ingrezza
meeting
in vitro
CTI BioPharma Announces Oral Presentation at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition
Published:
2022-11-03
(Crawled : 19:00)
- biospace.com/
CTIC
|
$9.09
0.05%
11M
|
Health Technology
|
85.61%
|
O:
2.24%
H:
3.29%
C:
0.2%
biopharma
meeting
presentation
Pediatric Health Market Research Report by Type, Therapeutics, Treatment, Treatment Type, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published:
2022-11-03
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
8.36%
|
O:
-0.02%
H:
0.43%
C:
0.43%
AZNCF
|
News
|
$135.35
-3.53%
-4.19%
400
|
Health Technology
|
11.91%
|
O:
-1.02%
H:
2.67%
C:
0.18%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
45.46%
|
O:
2.28%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
4.4M
|
Health Technology
|
19.44%
|
O:
0.83%
H:
1.33%
C:
-0.51%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
22.36%
|
O:
1.13%
H:
0.63%
C:
0.53%
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
107.98%
|
O:
0.97%
H:
0.18%
C:
-2.13%
BMY
|
$48.86
-0.27%
0.98%
14M
|
Health Technology
|
-37.74%
|
O:
0.42%
H:
0.59%
C:
-0.04%
ABT
|
News
|
$106.89
-0.65%
-0.09%
4.2M
|
Health Technology
|
10.82%
|
O:
1.43%
H:
0.41%
C:
0.25%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
11.82%
|
O:
2.05%
H:
0.0%
C:
0.0%
GILD
|
$67.08
0.08%
0.06%
6.2M
|
Health Technology
|
-15.58%
|
O:
-0.4%
H:
2.75%
C:
1.52%
AZN
|
News
|
$71.2
0.49%
0.46%
5.4M
|
Health Technology
|
18.81%
|
O:
0.72%
H:
1.29%
C:
1.04%
covid-19
treatment
research
global
report
impact
health
market
Co-Diagnostics, Inc. to Host Booth at AMP This Week in Phoenix, AZ
Published:
2022-11-03
(Crawled : 19:00)
- prnewswire.com
CODX
|
$1.14
-0.87%
1.71%
33K
|
Health Technology
|
-66.96%
|
O:
0.0%
H:
3.14%
C:
0.58%
week
Syndax Announces Positive Updates to Clinical Activity and Durable Remissions in Phase 1 Portion of AUGMENT-101 Trial of Revumenib in Patients with Acute Leukemias
Published:
2022-11-03
(Crawled : 19:00)
- biospace.com/
SNDX
|
$20.79
-0.86%
-0.87%
370K
|
Health Technology
|
-9.17%
|
O:
-0.57%
H:
13.62%
C:
-1.89%
gment-101
trial
positive
phase 1
Worldwide Consumer Induction Cooktop Industry to 2027 - Increasing Number of Large Residential Buildings in India With Limited Space is Leading Consumers to Opt for Space-Saving Induction Cooktops
Published:
2022-11-03
(Crawled : 17:00)
- prnewswire.com
PCRFF
|
News
|
$8.805
-0.85%
-1.12%
1.4K
|
n/a
|
3.77%
|
O:
1.42%
H:
0.0%
C:
-3.37%
PCRFY
|
News
|
$9.52
-0.11%
420K
|
n/a
|
14.15%
|
O:
-1.68%
H:
1.83%
C:
1.46%
PHG
|
News
|
$20.97
-0.19%
0.0%
650K
|
Health Technology
|
74.14%
|
O:
-3.42%
H:
0.0%
C:
-3.29%
space
india
Genmab Improves Its 2022 Financial Guidance
Published:
2022-11-03
(Crawled : 17:00)
- globenewswire.com
GNMSF
|
News
|
$290.34
0.23%
3.83%
1.2K
|
Health Technology
|
-27.36%
|
O:
-2.44%
H:
5.65%
C:
5.65%
GMAB
|
News
|
$28.47
-0.32%
-0.32%
430K
|
Health Technology
|
-26.66%
|
O:
-1.73%
H:
4.51%
C:
3.15%
financial
Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
Published:
2022-11-03
(Crawled : 16:00)
- prnewswire.com
GNMSF
|
News
|
$290.34
0.23%
3.83%
1.2K
|
Health Technology
|
-27.36%
|
O:
-2.44%
H:
5.65%
C:
5.65%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-14.2%
|
O:
-1.58%
H:
0.0%
C:
0.0%
GMAB
|
News
|
$28.47
-0.32%
-0.32%
430K
|
Health Technology
|
-26.66%
|
O:
-1.73%
H:
4.51%
C:
3.15%
GlycoMimetics Announces New Uproleselan Clinical Data in Both Frontline Unfit and Treated Secondary Acute Myeloid Leukemia Will Be Presented at ASH Annual Meeting
Published:
2022-11-03
(Crawled : 15:20)
- biospace.com/
GLYC
|
$1.855
1.09%
1.08%
650K
|
Health Technology
|
161.45%
|
O:
-1.43%
H:
2.39%
C:
-0.76%
meeting
leukemia
acute myeloid leukemia
← Previous
1
2
3
4
5
6
7
8
Next →
Gainers vs Losers
61%
39%
Top 10 Gainers
CSSE
4
|
$0.4253
179.25%
64.77%
210M
|
Consumer Services
BOF
|
$2.08
77.78%
41.21%
110M
|
ILAG
|
$0.54
12.27%
40.62%
3.7M
|
LICN
|
$0.999
78.39%
40.49%
15M
|
AMST
|
$3.4
70.0%
39.58%
70M
|
Technology Services
MTC
|
$3.6
60.71%
38.04%
9.1M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.458
14.5%
30.92%
91K
|
Health Services
WHLM
|
$6.25
35.87%
28.46%
700K
|
Commercial Services
MULN
|
News
|
$3.77
38.1%
27.78%
13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.